
Neurology
Low-Dose Naltrexone Remains Unproven for Long COVID
Small studies report improvements in fatigue, cognition, sleep and pain among people with long COVID, but a systematic review rates the evidence as low certainty.
Dr. Abu Bakar · September 13, 2026 · 6 min
